CIBC Private Wealth Group
GTBP icon

CIBC Private Wealth Group’s GT Biopharma GTBP Stock Holding History

CIBC Private Wealth Group’s Portfolio GTBP Stock Details GTBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.57K Buy
+2,000
New +$1.42K ﹤0.01% 2843

Other funds holding GTBP

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SRL
Scientech Research LLC Jersey City, New Jersey $120M AUM 73.62% 1-Year Est. Return
SWM
SeaCrest Wealth Management Purchase, New York $903M AUM 47.26% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
IWC
Integrated Wealth Concepts Waltham, Massachusetts $12.5B AUM 18.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CMP
Coston McIsaac & Partners Bar Harbor, Maine $443M AUM 6.68% 1-Year Est. Return
CJ
Caitlin John Brighton, Michigan $167M AUM 23.74% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

CIBC Private Wealth Group's GTBP Position: Q4 2025 in Review

CIBC Private Wealth Group opened a new position in GT Biopharma (GTBP) in Q4 2025: 2,000 shares worth $1.57K. The stake represents ﹤0.01% of the portfolio and ranks #2843 among its holdings.

38 funds tracked by Wall St. Rank hold GTBP as of Q4 2025.

  • CIBC Private Wealth Group held 2,000 shares of GT Biopharma worth $1.57K as of Q4 2025.
  • GT Biopharma was a new CIBC Private Wealth Group position in Q4 2025.
  • GT Biopharma made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #2843 holding.
  • 38 funds tracked by Wall St. Rank held GT Biopharma as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.